ARCHIVES

Cancer Advocacy: Deal Returns $3M to Office of Women’s Health, Spends $3.5M On Workshops

This article is from The Cancer Letter archive.

Vol. 23 No. 30 | August 1, 1997

Download PDF Visit The Full Archive

Related Articles

Olaparib Study Demonstrates No Changes In Overall Survival

March 30, 2012

Oncogens Variations May Exaplin Susceptibility, Familial Cancer, USC Investigators Report

September 23, 1988

New Jersey Legislature Votes to Oppose USPSTF PSA Screening Downgrade

January 20, 2012

In brief: Cancer Investment “Drop In The Bucket,” OMB Is The “Second Greatest Kill,” Pepper Says

August 10, 1979

In Brief: RFP Offers Patent Rights Instead Of Profit; ACS, NCI Plan More Joint Projects; BC Report Sept. 30

September 20, 1974

Biotherapeutics Reports LAK/IL-2 Toxicity Reduced With Constant Infusion Of IL-2

April 17, 1987